Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

apc pharmaceuticals & chemicals (europe) ltd - ciprofloxacin hydrochloride - oral tablet - 500mg

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

alissa healthcare research ltd - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

ABD - İngilizce - NLM (National Library of Medicine)

strides pharma science limited - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets are indicated for relief of mild to moderate pain. ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted. ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and  precautions, preexisting asthma ). ibuprofen tablets are contraindicated in the setting of coronary artery bypass graft (cabg) surgery (see warnings ).

ABD - İngilizce - NLM (National Library of Medicine)

strides pharma science limited - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole tablets are not indicated for treatment of onychomycosis, cutaneous dermatophyte infections, or candida infections. ketoconazole tablets should be used only when other effective antifungal therapy is not available or tolerated and the potential benefits are considered to outweigh the potential risks. ketoconazole tablets are indicated for the treatment of the following systemic fungal infections in patients who have failed or who are intolerant to other therapies: blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebrospinal fluid. drug interactions coadministration of a number of cyp3a4 substrates such as dofetilide, quinidine cisapride and pimozide is contraindicated with ketoconazole tablets. coadministration with ketoconazole can cause elevated plasma concentrations of these drugs and may increase or prolong both therapeutic and adverse effects to s

ABD - İngilizce - NLM (National Library of Medicine)

strides pharma science limited - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin capsules are indicated for: - management of postherpetic neuralgia in adults - adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin, during pregnancy. encourage women who are taking gabapentin capsules during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/ . risk summary there are no adequate data on the developmental risks associated with the use of gabapentin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmen

Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

strides pharma (sa) (pty) ltd - tablet - see ingredients - tablet cefadroxil (monohydrate) 262,35 mg

Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

strides pharma (sa) (pty) ltd - syrup - see ingredients - each 5,0 ml syrup contains prednisolone 15,0 mg

Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

strides pharma (sa) (pty) ltd - tablet - see ingredients - each tablet contains cefuroxime axetil 500,0 mg

Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

strides pharma (sa) (pty) ltd - capsules - see ingredients - each capsule contains ramipril 1,25 mg

Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

strides pharma (sa) (pty) ltd - capsules - see ingredients - each capsule contains ramipril 5,0 mg